Biolidics Ltd
SGX:8YY

Watchlist Manager
Biolidics Ltd Logo
Biolidics Ltd
SGX:8YY
Watchlist
Price: 0.037 SGD -5.13% Market Closed
Market Cap: 64.1m SGD
Section:
 

Relative Value

8YY doesn't have a meaningful market cap.

The Relative Value of one 8YY stock under the Base Case scenario is 0.001 SGD. Compared to the current market price of 0.037 SGD, Biolidics Ltd is Overvalued by 97%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

8YY Relative Value
Base Case
0.001 SGD
Overvaluation 97%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

81.8
P/S
P/S
Price to Sales
81.8
vs History
28
vs Industry
4
Median 3Y
50.9
Median 5Y
58.4
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-7.2
Median 5Y
-11.6
Industry
22.4
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-12.3
Median 5Y
-17.3
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-7.4
Median 5Y
-9.1
Industry
21.5
More Details
37.1
P/B
P/B
Price to Book Value
37.1
vs History
31
vs Industry
1
Median 3Y
-10.3
Median 5Y
22
Industry
2.2
More Details
82.3
EV/S
EV/S
Enterprise Value to Sales
82.3
vs History
28
vs Industry
3
Median 3Y
51.3
Median 5Y
57.7
Industry
2.5
More Details
345
EV/GP
EV/GP
Enterprise Value to Gross Profit
345
vs History
17
vs Industry
1
Median 3Y
153.4
Median 5Y
164.4
Industry
5.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-10.1
Median 5Y
-13.7
Industry
12
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-8.7
Median 5Y
-13.2
Industry
17.1
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-11.6
Median 5Y
-17.4
Industry
14.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-11.5
Median 5Y
-17.4
Industry
18.8
More Details
15.4
EV/IC
EV/IC
Enterprise Value to IC
15.4
vs History
73
vs Industry
6
Median 3Y
35.7
Median 5Y
38
Industry
1.8
More Details

Multiples Across Competitors

8YY Competitors Multiples
Biolidics Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SG
Biolidics Ltd
SGX:8YY
64.1m SGD 81.8 -18.7 -21.9 -21.1
US
Abbott Laboratories
NYSE:ABT
221B USD 5 15.8 20.2 28
US
Intuitive Surgical Inc
NASDAQ:ISRG
200.8B USD 20.9 73.4 56 68.3
US
Boston Scientific Corp
NYSE:BSX
142.8B USD 7.4 51.1 29.9 40.7
US
Stryker Corp
NYSE:SYK
136B USD 5.6 46.4 22.6 27.3
IE
Medtronic PLC
NYSE:MDT
126.1B USD 3.6 26.5 14.9 21.5
DE
Siemens Healthineers AG
XETRA:SHL
49.7B EUR 2.1 23.3 13.1 18.5
US
Becton Dickinson and Co
NYSE:BDX
56.2B USD 2.6 33.5 12.4 21.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.2B USD 13.5 54.9 39.3 43.5
US
Edwards Lifesciences Corp
NYSE:EW
49.7B USD 8.4 36.4 26 28.4
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.8B USD 1.9 17.1 12.7 15.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SG
Biolidics Ltd
SGX:8YY
Average EV/EBITDA: 24.7
Negative Multiple: -21.9 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
20.2
12%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
56
26%
2.2
US
Boston Scientific Corp
NYSE:BSX
29.9
22%
1.4
US
Stryker Corp
NYSE:SYK
22.6
13%
1.7
IE
Medtronic PLC
NYSE:MDT
14.9
8%
1.9
DE
Siemens Healthineers AG
XETRA:SHL
13.1
11%
1.2
US
Becton Dickinson and Co
NYSE:BDX
12.4
9%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.3
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
26
13%
2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
12.7
10%
1.3

See Also

Summary
8YY intrinsic value, competitors valuation, and company profile.
DCF Valuation
8YY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
8YY stock valuation using valuation multiples.
Wall Street Estimates
8YY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
8YY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.